Table 1 HIV-related characteristics of the 263 patients included
From: Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients
Time elapsed since HIV diagnosis (years), mean +/− SD | 13 +/− 8 |
CDC stage A, n (%) | 101 (38.4) |
CDC stage B, n (%) | 75 (28.5) |
CDC stage C, n (%) | 87 (33.1) |
Karnofsky’s index %, mean +/− SD | 92 +/− 14 |
Time spent on NRTI (months), mean +/− SD | 95 +/− 71 |
Time spent on tenofovir (months), mean +/− SD | 25 +/− 27 |
Time spent on NNRTI (months), mean +/− SD | 40 +/− 47 |
Time spent on PI (months), mean +/− SD | 44 +/− 47 |
Without current antiretroviral therapy, n (%) | 22 (8.4) |
On HAART including NTI, n (%) | 210 (80.5) |
On HAART including tenofovir, n (%) | 164 (62.8) |
On HAART including NNTI, n (%) | 92 (35.4) |
On HAART including PI, n (%) | 151 (57.9) |
On HAART including II, n (%) | 21 (8.0) |
CD4 nadir (/mm3), mean +/− SD | 198 +/− 190 |
Time spent with undetectable HIV viral load (months), mean +/− SD | 58 +/− 45 |
Current CD4 (/mm3), mean +/− SD | 551 +/− 271 |
Current CD8 (/mm3), mean +/− SD | 810 +/− 420 |
Current CD4/CD8 ratio, mean +/− SD | 0.80 +/− 0.49 |
Current undetectable HIV viral load, n (%) | 207 (78.7%) |
Current HIV viral load (when detectable), log 10 copies/ml +/− SD | 3.1 +/− 1.2 |